Close

Abiomed (ABMD) Posts Q4 EPS of $0.70

April 30, 2020 7:04 AM EDT

Abiomed (NASDAQ: ABMD) reported Q4 EPS of $0.70, which may not compare to the analyst estimate of $0.94. Revenue for the quarter came in at $206.7 million versus the consensus estimate of $207.17 million.

For earnings history and earnings-related data on Abiomed (ABMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings